Maternal COVID-19 Vaccination May Reduce Neonatal Respiratory Distress
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 24, 2024 -- Maternal COVID-19 vaccination is associated with reduced frequency of neonatal respiratory distress (RD), according to a study published online Jan. 24 in Nature Communications.
Olivia M. Man, from the David Geffen School of Medicine at the University of California in Los Angeles, and colleagues examined the association between maternal COVID-19 vaccination and neonatal RD using a longitudinal cohort of mother-infant pairs. The study included 221 mothers with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy and 227 exposed fetuses.
The researchers found that SARS-CoV-2-exposed uninfected (SEU) infants had unusually high rates of RD (17 percent), with an odds ratio of 3.06 for RD in term neonates born to unvaccinated individuals compared with those born to individuals vaccinated before maternal infection. A robust inflammatory response associated with ciliary dysregulation and enhanced immunoglobulin E production was seen in a proteomic analysis among SEU infants with RD.
"Maternal vaccination against COVID-19 reduced maternal disease severity and the frequency of neonatal RD. Pregnant persons should be encouraged to receive mRNA COVID-19 vaccines, regardless of history of prior COVID-19 infection," the authors write. "More research is needed to understand the impact of maternal COVID-19 vaccination on long-term infant health and development, including chronic pulmonary conditions."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-25 22:15
Read more
- Listeria Danger Spurs Nationwide Recall of Frozen Waffles
- Delayed Meniere Disease Tied to Higher Prevalence of Bilateral Disease
- ACG: Hormone Therapy Tied to Higher Risk for New Irritable Bowel Syndrome
- Music Might Speed Your Recovery From Surgery
- U.S. Alcohol Intake Rose During Pandemic, and for Years After
- Half of Patients With Sepsis Die Within 2 Years, Hospital Study Finds
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions